To investigate the influence of antibiotics on the incidence of biliary tract infections after PTCD for malignant obstructive jaundice.
This project designed a large-scale, single-center, prospective randomized controlled clinical trial to explore the impact of antibiotics on the incidence of biliary tract infections after PTCD with malignant obstructive jaundice. This study will provide evidence-based medical evidence for the need for routine use of antibiotics to prevent biliary tract infections after PTCD with malignant obstructive jaundice, and provide references for clinicians to prevent patients from PTCD infections.
Study Type
OBSERVATIONAL
Enrollment
120
normal saline
Department of Pancreatic and Hepatobiliary Surgery, Fudan University Shanghai Cancer Center; Pancreatic Cancer Institute, Fudan University
Shanghai, Shanghai Municipality, China
RECRUITINGIncidence of patients with biliary tract infection after surgery
Incidence of patients with biliary tract infection after surgery
Time frame: October 2020 to June 2023
Decline rate of bilirubin in patients after PTCD
Decline rate of bilirubin in patients after PTCD
Time frame: October 2020 to June 2023
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.